Skip to main content

Advertisement

Log in

Milrinone as a Rescue Therapy for Symptomatic Refractory Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Introduction

Delayed ischemic neurological deficit associated to cerebral vasospasm is the most common cause of sequelae and death that follows the rupture of an aneurysm. The objective of this study was to evaluate the safety and efficacy of intra-arterial Milrinone in patients with symptomatic refractory cerebral vasospasm.

Patients and Method

Eight patients diagnosed with aneurysmal subarachnoid hemorrhage who developed symptomatic cerebral vasospasm refractory to conventional medical therapy were enrolled. They received an intra-arterial infusion of Milrinone at a rate of 0.25 mg/min, with a total dose of 10–15 mg. Qualitative evaluation of angiographic response, neurological and systemic complications as well as functional outcome at 3 months were documented.

Results

All patients had a significant angiographic response. This was evidenced by a pre-treatment vessel stenosis greater than 70%, that improved to less than 50% after the intra-arterial Milrinone infusion. Three patients developed recurrent vasospasm that improved after a second intra-arterial Milrinone infusion. None of the patients developed neurologic or systemic complications attributed to the intervention. At 3 months follow-up all patients were alive and had a mean modified Rankin scale of 2 ± 1 and a Barthel index of 83 ± 10.

Conclusion

Intra-arterial Milrinone infusion seems to be a safe and effective treatment for patients who develop refractory symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Lavados P, Sacks C, Prina L, et al. Incidence, 30-day case-fatality rate, and prognosis of stroke in Iquique, Chile: a 2-year community-based prospective study (PISCIS project). Lancet. 2005;365:2206–15.

    Article  PubMed  Google Scholar 

  2. Wood M, Nowitzke A. Epidemiological aspects of spontaneous subarachnoid haemorrhage in Queensland, Australia. J Clin Neurosci. 2005;12:770–4.

    Article  PubMed  Google Scholar 

  3. Hop J, Rinkel G, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28:660–4.

    PubMed  CAS  Google Scholar 

  4. Hop J, Rinkel G, Algra A, van Gijn J. Quality of life in patients and partners after aneurysmal sub arachnoid hemorrhage. Stroke. 1998;29:798–804.

    PubMed  CAS  Google Scholar 

  5. Suarez J, Tarr R, Selman W. Aneurysmal subarachnoid hemorrhage. N Engl J Med. 2006;354:387–96.

    Article  PubMed  CAS  Google Scholar 

  6. Dorsch N. Cerebral arterial spasm: a clinical review. Br J Neurosurg. 1995;9:403–12.

    Article  PubMed  CAS  Google Scholar 

  7. Dorsch N. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care. 2002;8:128–33.

    Article  PubMed  Google Scholar 

  8. Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Crit Care Med. 1995;23: 1007–17.

    Article  PubMed  CAS  Google Scholar 

  9. Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayes cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001; 32:2012–20.

    Article  PubMed  CAS  Google Scholar 

  10. Lee KH, Lukovits T, Friedman JA. “Triple-H” therapy for cerebral vasospasm following sub arachnoid hemorrhage. Neurocrit Care. 2006;4:68–76.

    Article  PubMed  Google Scholar 

  11. Liu JK, Couldwell WT. Intra-arterial papaverine infusions for the treatment of cerebral vasospasm induced by aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2005;2:124–32.

    Article  PubMed  Google Scholar 

  12. Tseng MY, Czosnyka M, Richards H, et al. Effect of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke. 2005;36:1627–32.

    Article  PubMed  CAS  Google Scholar 

  13. Van den Bergh WM. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011–5.

    Article  PubMed  CAS  Google Scholar 

  14. Dorhout Mees SM, Rinkel GJ, Hop JW, et al. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review. Stroke. 2003;34:2285–9.

    Article  PubMed  CAS  Google Scholar 

  15. Wurm G, Tomancok B, Nussbaumer K, et al. Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: a double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosug. 2004;106:97–103.

    Article  Google Scholar 

  16. Hamada J, Kai J, Morioka M, et al. Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna. A prospective randomized study. Stroke. 2003;34:2549–54.

    Article  PubMed  Google Scholar 

  17. Givertz M, Hare J, Loh E, et al. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol. 1996;28:1775–80.

    Article  PubMed  CAS  Google Scholar 

  18. Anderson JL, Baim DS, Fein SA, et al. Efficacy and safety of sustained (48 hour) intravenous infusion of milrinone in patients with severe congestive heart failure: a multicenter study. J Am Coll Cardiol. 1987;9:711–22.

    Article  PubMed  CAS  Google Scholar 

  19. Bayram M, De Luca L, Massie MB, et al. Reassessment of dobutamine, dopamine and milrinone in the management of acute heart failure syndromes. Am J Cardiol. 2005;96(Suppl):47G–58G.

    Article  PubMed  CAS  Google Scholar 

  20. Arakawa Y, Kikuta K, Hojo M, et al. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery. 2001;48:723–30.

    Article  PubMed  CAS  Google Scholar 

  21. Arakawa Y, Kikuta K, Hojo M, et al. Milrinone reduces cerebral vasospasm after subarachnoid hemorrhage grade IV or V. Neurol Med Chir (Tokio). 2004;44:393–401.

    Article  Google Scholar 

  22. Lindegaard K, Normes H, Bakke S, et al. Cerebral vasospasm after subarachnoid hemorrhage investigated by means of transcranial doppler ultrasound. Acta Neurochir Suppl (Wien). 1988;42:81–4.

    CAS  Google Scholar 

  23. Soustiel J, Shik V, Shreiber R, et al. Basilar vasospasm diagnosis. Investigation of a modified “Lindegaard Index” based on imaging studies and blood velocity measurements of basilar artery. Stroke. 2002;33:72–8.

    Article  PubMed  Google Scholar 

  24. Hansen-Schwartz J. Cerebral vasospasm. A consideration of the various cellular mechanism involved in the pathophysiology. Neurocrit Care. 2004;1:235–46.

    Article  PubMed  CAS  Google Scholar 

  25. Dorsch NW. A review of cerebral vasospasm in aneurismal subarachnoid hemorrhage. Part II: management. J Clin Neurosci. 1994;1:78–92.

    Article  PubMed  CAS  Google Scholar 

  26. Polin RS, Hansen CA, German P, et al. Intra-arterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery. 1998;42:1256–67.

    Article  PubMed  CAS  Google Scholar 

  27. Kassell NF, Helm G, Simmons N, et al. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77:848–52.

    Article  PubMed  CAS  Google Scholar 

  28. Yoshida K, Watanabe H, Nakamura S. Intra-arterial injection of amrinone for vasospasm induced by subarachnoid hemorrhage. Am J Neuroradiol. 1997;18:492–6.

    PubMed  CAS  Google Scholar 

  29. Khajavi K, Ayzman I, Shearer D, et al. Prevention of chronic cerebral vasospasm in dogs with milrinone. Neurosurgery. 1997;40:354–62.

    Article  PubMed  CAS  Google Scholar 

  30. Linn FH, Rinkel GJ, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke. 1996;27:625–9.

    PubMed  CAS  Google Scholar 

  31. Lambert G, Naredi S, Edén E, et al. Monoamine metabolism and sympathetic nervous activation following subarachnoid haemorrhage: influence of gender and hydrocephalus. Brain Res Bull. 2002;58:77–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. M. Romero.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romero, C.M., Morales, D., Reccius, A. et al. Milrinone as a Rescue Therapy for Symptomatic Refractory Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care 11, 165–171 (2009). https://doi.org/10.1007/s12028-008-9048-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-008-9048-0

Keywords

Navigation